X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Default Eligibility Results In Better Clinical Trial Nods

    Researchers Develop Revolutionary Treatment In Bone Cancer

    Singapore Precision Drugs To Excel By Next-Gen Proteomics

    Temperature Stable TB Vaccine Gives Out Immune Response

    T Cells Are Fruitful In Thwarting-Off Chronic Infections

    Randomness Drives Tumour Cells Response To Chemotherapy

    mAbs And Therapeutic Proteins Potency Guidance Issued By FDA

    Novel Purification Means For Protein Drug Manufacturing

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Default Eligibility Results In Better Clinical Trial Nods

    Researchers Develop Revolutionary Treatment In Bone Cancer

    Singapore Precision Drugs To Excel By Next-Gen Proteomics

    Temperature Stable TB Vaccine Gives Out Immune Response

    T Cells Are Fruitful In Thwarting-Off Chronic Infections

    Randomness Drives Tumour Cells Response To Chemotherapy

    mAbs And Therapeutic Proteins Potency Guidance Issued By FDA

    Novel Purification Means For Protein Drug Manufacturing

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

    $118bn Sales By 2026 Is What Japanese Pharma Can Expect

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Default Eligibility Results In Better Clinical Trial Nods

Content Team by Content Team
10th March 2023
in News, Research & Development

A new approach that has been created at the Medical University of South Carolina that specifically aims at enhancing clinical trial eligibility has shown positive results.

The patient outreach recruitment team that has been floated by the South Carolina Clinical and Translational Research Institute has made potential patients eligible by default. This has helped them learn about clinical trials in which they can participate. Patients were signaled by default pertaining to the research opportunities and also had the provision to opt out.

The team went on to discuss the new approach in the Clinical and Translational Sciences Journal. They learned from many of their patients that they would like to have a better opportunity when it comes to participating in the research; however, they had no knowledge of the said opportunities, said Associate Vice President, Clinical Research at MUSC, Dr.Patrick Flume.

They believe that the opt-out option in all possibilities grants individuals the autonomy to choose if they want to be a part of the research, according to recruitment manager Tara Pittman. By way of this new approach, to enhance eligibility in clinical trials, individuals within the MUSC Health System are registered across the research participant pool. This primarily increased the number of potential participants to 1.7 million. As per Pittman, patient burnout decreased, and it was highly unlikely that he or she would be contacted more than once or twice. That’s because the same patients who were a part of the trial before the change were no longer subject to receiving repeated requests from the research teams. Initially, the POR team had reservations about whether patients might not like being contacted multiple times pertaining to the studies, and therefore safeguards were put in place to take care of it. That said, all this was found to be unnecessary since the repeat contact went on to be well received by the patients.

To gauge whether the POR approach decidedly elevates the enrolment as well as diversity, more information needs to be looked into, and that information can arise from the recently implemented clinical trial management system by MUSC.

Apparently, if the individuals’ participation as well as diversity see an increase, the POR approach can very well become a vital new tool when it comes to research recruitment toolkits.

Previous Post

Researchers Develop Revolutionary Treatment In Bone Cancer

Related Posts

News

Researchers Develop Revolutionary Treatment In Bone Cancer

10th March 2023
Drug Development

Singapore Precision Drugs To Excel By Next-Gen Proteomics

10th March 2023
Clinical Trials

Temperature Stable TB Vaccine Gives Out Immune Response

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
News

Randomness Drives Tumour Cells Response To Chemotherapy

10th March 2023
Drug Development

mAbs And Therapeutic Proteins Potency Guidance Issued By FDA

9th March 2023

Latest News

News

Default Eligibility Results In Better Clinical Trial Nods

10th March 2023
News

Researchers Develop Revolutionary Treatment In Bone Cancer

10th March 2023
Drug Development

Singapore Precision Drugs To Excel By Next-Gen Proteomics

10th March 2023
Clinical Trials

Temperature Stable TB Vaccine Gives Out Immune Response

10th March 2023
News

T Cells Are Fruitful In Thwarting-Off Chronic Infections

10th March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In